Health & wellbeing

Mart Saarma, researcher and academy professor at the Institute of Biotechnology, University of Helsinki, has shown that a protein called CDNF is effective in treating some aspects of Parkinson’s.PARKINSON’S Disease is not a new disease, nor a new challenge. In spite of the disease’s many unknowns, the Finnish health system and its stakeholders are becoming more effective in supporting individuals living with Parkinson’s as well as leading innovative research to find a cure.

More than 15,000 people in Finland live with the disease, which has symptoms ranging from a slight tremor to loss of voice to depression and physical incapacitation. The composition and intensity of symptoms are as individual as the patients are, making treatment and research challenging.

Supporting Parkinson’s patients

One of the greatest challenges faced today by the Parkinson’s community is awareness. Much remains to be done to better educate and inform the public and medical practitioners about the process of diagnosing Parkinson’s as well as the options for treatment and care. In the same vein, educating doctors about the importance of referring patients to neurologists and movement disorder specialists is crucial to providing effective care for each individual patient.

What is it?

Parkinson’s disease is a chronic, degenerative neurological disorder that affects one in 100 people over age 60, more than 15,000 Finns and over 5 million worldwide.

What causes Parkinson’s Disease?

A definitive cause of Parkinson’s is not known, but both genetic and environmental factors are believed to play a role.

What are the symptoms?

While the symptoms manifest differently in every individual, the cardinal symptoms are resting tremor, slowness of movement, postural instability (balance problems) and rigidity.

How is it diagnosed?

There are no definitive tests to diagnose Parkinson’s disease. Health care professionals who suspect Parkinson’s in a patient will examine medical history and conduct neurological exams, looking for the presence of two or more cardinal Parkinson’s symptoms.

What treatments are available?

Most treatments attempt to control symptoms by sending more dopamine to the brain. Surgical intervention, such as deep brain stimulation, may also be appropriate. Current treatments are symptomatic in nature — the underlying disease continues to worsen. It is recommended that Parkinson’s patients be seen by a movement disorder specialist, who is usually the most up-to-date on current best practices in treatment.

That being said, Finland boasts one of the most comprehensive support networks for Parkinson’s patients. Ariel Gordin, the Chairman of the Finnish Parkinson Association, points out that Finland is ‘one of the few countries in Europe that has its own rehabilitation facilities specifically for Parkinson’s’, which provide increased access to specialised programmes that support patients through all stages of their treatment.

Those receiving Parkinson’s treatment in Finland can use the public health system, as well as visiting private clinics. Unlike other countries, these separate public and private options complement one another and work well for Parkinson’s patients. In addition, all Parkinson’s medication is 100 per cent free to patients, as are surgical procedures, including deep brain stimulation and levodopa pumps, which are used when the patient’s symptoms cannot be adequately controlled through standard medication delivery.


Matthew Mitchell

Only a fraction of the articles are available to public, please subscribe to be able to read whole article on the digital paper.

Please check our subscription periods and prices from here.

Read Helsinki Times with a subscriber code
Helsinki Times's digital paper has moved to our partner's website, LEHTILUUKKU.FI

Helsinki Times can be read with a subscriber code provided by the publisher or subscription office.

If you have received a subscriber code from the Helsinki Times, you may attach it to your Lehtiluukku user account to gain free access to Helsinki Times. The same subscriber code is valid for iPad and iPhone Helsinki Times' application.